CEO Statement
Corline® is a Life Science company dedicated to enhancing the well-being of patients by providing solutions that improve our OEM customers’ clinical products.
Corline® supplies biocompatible and pro-healing solutions based on a unique and proprietary surface modification technology platform, which is proven and supported by scientific reports in a multitude of applications, both for traditional medical devices and for the developing field of regenerative medicine. The Corline® Heparin Surface – CHS™ - technology offers endless improvement and development opportunities for current and future clinical grade products.
Corline® is committed to helping our customers and exceeding their expectations. We do so by closely partnering with customers in problem solving processes and for ramp-up and delivery. We also provide true innovation by leveraging our excellent staff as well as other internal development resources, and those of our well-renowned external research partners.
By working with world-leading customers we strive to challenge ourselves to further improve our capabilities, and we hope that committment will show through-out our website.
Welcome, and thank you for the interest you show for us and our products.
Henrik Nittmar
CEO
